D2 Versus D4 Corifollitropin Alfa in GnRH Antagonists
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to analyse if corifollitropin alfa, an agent for
prolonged ovarian stimulation, administered from day 4 can be clinically used instead of day
2 onwards for a controlled ovarian hyperstimulation (COH) in an antagonist protocol.